Form 4 for CDNA CareDx, Inc.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001217234-23-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-03 | 2023-02-01+ | CDNA | Johnson Alexander L | Chief Business Off | F - Tax | $17.01 | -3,481 | 200.0K | -2% | -$59.2K |
| DM | 2023-02-03 | 2023-02-01 | CDNA | Johnson Alexander L | Chief Business Off | A - Grant | $0.00 | +88.3K | 197.4K | +81% | $0 |
| D | 2023-02-03 | 2023-02-01 | CDNA | Johnson Alexander L | Chief Business Off | A - Grant | $0.00 | +44.1K | 44.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | F | D | 417 | $16.54 | 197,169 | D | — | — | (F4) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2023-02-03 | F | D | 417 | $16.54 | 197,586 | D | — | — | (F4) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2023-02-02 | F | D | 2,029 | $17.61 | 198,003 | D | — | — | (F4) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
| 4 | Common | Common Stock | 2023-02-01 | F | D | 618 | $15.66 | 200,032 | D | — | — | (F3) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of performance restricted stock units. |
| 5 | Common | Common Stock | 2023-02-01 | A | A | 3,200 | $0.00 | 200,650 | D | — | — | (F2) The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer. |
| 6 | Common | Common Stock | 2023-02-01 | A | A | 85,100 | $0.00 | 197,450 | D | — | — | (F1) The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 1, 2024 and 1/4th of which shall vest on each anniversary thereafter. |
| 7 | Derivative | Stock Option (right to buy) | 2023-02-01 | A | A | 44,100 | $0.00 | 44,100 | D | $15.66 · — to 2033-02-01 | 44,100 Common Stock | (F5) 1/4th of the shares subject to the option shall vest on February 1, 2024 and 1/48th of the shares subject to the option shall vest monthly thereafter. |